Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medinotec (MDNC) Shares Outstanding (Weighted Average) (2023 - 2025)

Historic Shares Outstanding (Weighted Average) for Medinotec (MDNC) over the last 3 years, with Q2 2025 value amounting to $11.7 million.

  • Medinotec's Shares Outstanding (Weighted Average) changed 0.0% to $11.7 million in Q2 2025 from the same period last year, while for May 2025 it was $11.7 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $11.7 million for FY2025, which is 0.0% changed from last year.
  • Latest data reveals that Medinotec reported Shares Outstanding (Weighted Average) of $11.7 million as of Q2 2025, which was down 0.0% from $11.7 million recorded in Q1 2025.
  • Over the past 5 years, Medinotec's Shares Outstanding (Weighted Average) peaked at $11.7 million during Q1 2023, and registered a low of $11.7 million during Q1 2023.
  • For the 3-year period, Medinotec's Shares Outstanding (Weighted Average) averaged around $11.7 million, with its median value being $11.7 million (2023).
  • The largest annual percentage gain for Medinotec's Shares Outstanding (Weighted Average) in the last 5 years was 0.0% (2024), contrasted with its biggest fall of 0.0% (2024).
  • Medinotec's Shares Outstanding (Weighted Average) (Quarter) stood at $11.7 million in 2023, then changed by 0.0% to $11.7 million in 2024, then changed by 0.0% to $11.7 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $11.7 million in Q2 2025, compared to $11.7 million in Q1 2025 and $11.7 million in Q2 2024.